Experts Drs Stanley Cohen and Arthur Kavanaugh give busy clinicians a rundown of what's new and noteworthy in the 2021 GRAPPA guidelines update. News & Perspective Drugs & Diseases ...

Both GRAPPA and ASAS plan to use the term "difficult-to-treat" or "treatment refractory" to describe true biologically refractory inflammatory disease and are categorizing the larger, heterogenous ...

A new publication by the GRAPPA–OMERACT group provides recommendations and a useful framework for physicians on the use of composite measures and treatment targets in psoriatic arthritis.